Mieko Ogino

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

Life Sciences, Neurology, Neuroscience +11

Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness

Terumi Murakami, Yukiko Hayashi, S. Noguchi et al. · Annals of Neurology · 2006 · 149 citations · Full text

Medicine, Genetics, Molecular Genetics +13

Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan

Toshio Shimizu, Utako Nagaoka, Yuki Nakayama et al. · Amyotrophic Lateral Sclerosis · 2012 · 114 citations

Medicine, Neurology, Clinical Epidemiology +15

Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection

Sachiko Irie, Toyokazu Saito, Naomi Kanazawa et al. · Journal of Neuroimmunology · 1996 · 90 citations

Life Sciences, Immunology, Neurology +11

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 85 citations · Full text

Life Sciences, Neurology, Neuroscience +10